Primary |
Pain |
50.0% |
Urinary Tract Infection |
50.0% |
|
Haemolysis |
20.0% |
Hepatitis |
20.0% |
Rash |
20.0% |
Skin Discolouration |
20.0% |
Urine Output Decreased |
20.0% |
|
Secondary |
Product Used For Unknown Indication |
22.1% |
Off Label Use |
9.3% |
Bladder Pain |
7.0% |
Dyspnoea |
7.0% |
Micturition Urgency |
7.0% |
Nasopharyngitis |
7.0% |
Urinary Retention |
7.0% |
Pain |
5.8% |
Insomnia |
4.7% |
Pyrexia |
4.7% |
Diarrhoea |
3.5% |
Nausea |
2.3% |
Non-small Cell Lung Cancer |
2.3% |
Prophylaxis |
2.3% |
Vertigo |
2.3% |
Constipation |
1.2% |
Cough |
1.2% |
Decreased Appetite |
1.2% |
Dysuria |
1.2% |
Flank Pain |
1.2% |
|
Toxicity To Various Agents |
33.3% |
Liver Injury |
16.7% |
Yellow Skin |
16.7% |
Drug Hypersensitivity |
8.3% |
Pneumonia |
8.3% |
Urticaria |
8.3% |
Vocal Cord Inflammation |
8.3% |
|
Concomitant |
Product Used For Unknown Indication |
64.8% |
Pain |
4.3% |
Gastrooesophageal Reflux Disease |
3.9% |
Contraception |
2.4% |
Anxiety |
1.9% |
Back Pain |
1.9% |
Drug Use For Unknown Indication |
1.9% |
Cardiac Disorder |
1.7% |
Depression |
1.7% |
Migraine |
1.7% |
Rheumatoid Arthritis |
1.7% |
Urinary Tract Infection |
1.7% |
Bladder Spasm |
1.5% |
Dysuria |
1.5% |
Nausea |
1.4% |
Prophylaxis |
1.4% |
Muscle Spasms |
1.2% |
Smoking Cessation Therapy |
1.2% |
Acne |
1.0% |
Arthritis |
1.0% |
|
Pulmonary Embolism |
13.8% |
Vomiting |
10.0% |
Weight Increased |
8.8% |
Weight Decreased |
7.5% |
Pain |
6.3% |
Renal Failure Acute |
5.0% |
Tachycardia |
5.0% |
Thrombosis |
5.0% |
Urinary Tract Infection |
5.0% |
Myocardial Infarction |
3.8% |
Tardive Dyskinesia |
3.8% |
Thrombophlebitis Superficial |
3.8% |
Vitamin D Deficiency |
3.8% |
White Blood Cell Count Decreased |
3.8% |
Deep Vein Thrombosis |
2.5% |
Dry Mouth |
2.5% |
Lethargy |
2.5% |
Nausea |
2.5% |
Pelvic Venous Thrombosis |
2.5% |
Transient Ischaemic Attack |
2.5% |
|